Grey Wolf Health (TSXV:WOLF) Days Inventory: 123.23 (As of Mar. 2026) — Near Median


TSXV:WOLF Grey Wolf Health Corp TSXV:WOLF
52 GF Score
Price C$1.75
GF Value C$1.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Grey Wolf Health Days Inventory?

Grey Wolf Health TSXV:WOLF -1.69% 52 Days Inventory is 123.23 as of Mar. 2026, which is 1% above its 10-year median of 121.73. GuruFocus rates TSXV:WOLF with a GF Score™ of 52/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 919 Drug Manufacturers companies, Grey Wolf Health ranks better than 69.42% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Grey Wolf Health's Average Total Inventories for the three months ended in Mar. 2026 was C$5.43 Mil. Grey Wolf Health's Cost of Goods Sold for the three months ended in Mar. 2026 was C$4.02 Mil. Hence, Grey Wolf Health's Days Inventory for the three months ended in Mar. 2026 was 123.23.

The historical rank and industry rank for Grey Wolf Health's Days Inventory or its related term are showing as below:

TSXV:WOLF' s Days Inventory Range Over the Past 10 Years
Min: 109.36   Med: 121.73   Max: 176.12
Current: 121.53

During the past 5 years, Grey Wolf Health's highest Days Inventory was 176.12. The lowest was 109.36. And the median was 121.73.

TSXV:WOLF's Days Inventory is ranked better than
69.42% of 919 companies
in the Drug Manufacturers industry
Industry Median: 164.38 vs TSXV:WOLF: 121.53

Grey Wolf Health's Days Inventory declined from Mar. 2025 (134.22) to Mar. 2026 (123.23).

Inventory Turnover measures how fast the company turns over its inventory within a year. Grey Wolf Health's Inventory Turnover for the three months ended in Mar. 2026 was 0.74.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Grey Wolf Health's Inventory-to-Revenue for the three months ended in Mar. 2026 was 0.62.


Grey Wolf Health  (TSXV:WOLF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Grey Wolf Health's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Grey Wolf Health's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Grey Wolf Health Days Inventory Related Terms


Grey Wolf Health Days Inventory Historical Data

* Premium members only.

The historical data trend for Grey Wolf Health's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Health Days Inventory Chart

Grey Wolf Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
176.12 109.36 121.73 141.08 120.57

Grey Wolf Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.22 122.62 122.16 122.91 123.23

TSXV:WOLF vs ROL, SCI, FTDR: Days Inventory Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grey Wolf Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grey Wolf Health Days Inventory vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grey Wolf Health's Days Inventory distribution charts can be found below:

* The bar in red indicates where Grey Wolf Health's Days Inventory falls into.


TSXV:WOLF
52GF Score
Grey Wolf Health Corp TSXV:WOLF
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Wolf Health Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Grey Wolf Health's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (5.476 + 5.559) / 2 ) / 16.703*365
=5.5175 / 16.703*365
=120.57

Grey Wolf Health's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (5.559 + 5.299) / 2 ) / 4.02*365 / 4
=5.429 / 4.02*365 / 4
=123.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 123.23 mean?
Grey Wolf Health (TSXV:WOLF) has a Days Inventory of 123.23 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grey Wolf Health and its competitors. This is near median its historical median of 121.73. Over the past decade, Grey Wolf Health's Days Inventory has ranged from 109.36 to 176.12. According to the industry distribution chart, Grey Wolf Health ranks #281 out of 919 companies in the Drug Manufacturers industry, placing it in the top 30.6%.
Is Grey Wolf Health's Days Inventory too high?
Grey Wolf Health's current Days Inventory of 123.23 is near median its 10-year median of 121.73. Over the past 10 years, this metric has ranged from a low of 109.36 to a high of 176.12. The Drug Manufacturers industry median Days Inventory is 164.38. Grey Wolf Health's value of 123.23 is 25% below this industry median. Based on the distribution chart, Grey Wolf Health ranks #281 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Grey Wolf Health has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's Days Inventory compare to ROL and SCI?
According to the Drug Manufacturers industry distribution chart, Grey Wolf Health ranks #281 out of 919 companies for Days Inventory. This puts Grey Wolf Health in the upper half of its industry. The industry median Days Inventory is 164.38. Grey Wolf Health's value of 123.23 is 25% below this benchmark. Historically, Grey Wolf Health's own Days Inventory has ranged from 109.36 to 176.12 over the past decade. While the company's 10-year median is 121.73 vs. the industry median of 164.38, Grey Wolf Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grey Wolf Health's current Days Inventory of 123.23 is 25% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grey Wolf Health and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grey Wolf Health's current Days Inventory is 123.23, which is near median its own 10-year median of 121.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.75 — trading 59.1% above its estimated fair value. The current Days Inventory is 123.23, which is near median its 10-year median of 121.73 and 25% below the Drug Manufacturers industry median of 164.38. Grey Wolf Health's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current Days Inventory is 123.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?

Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued. The current stock price of C$1.75 is trading 59.1% above its estimated GF Value™ of C$1.10. GuruFocus considers Grey Wolf Health to be Significantly Overvalued.

Key valuation signals for TSXV:WOLF:

  • Days Inventory: 123.23 (near median its 10-year median of 121.73)
  • GF Value™: C$1.10 vs. price of C$1.75 (59.1% above fair value)
  • GF Score™: 52/100 with 5 warning signs
  • Industry Position: 25% below the Drug Manufacturers median (#281 of 919)

No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Grey Wolf Health Business Description

Address 100 King Street West, Suite 6000, 1 First Canadian Place, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
52GF Score

Get the complete analysis for TSXV:WOLF

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.75
Price
C$1.10
GF Value